Ginsenosides Rg1 and Re act as adjuvant via TLR4 signaling pathway. (Q53942774)

22 May 2018

title

Ginsenosides Rg1 and Re act as adjuvant via TLR4 signaling pathway. (English)

1 reference

22 May 2018

0 references

Fei Su

1

1 reference

22 May 2018

Lin Yuan

series ordinal

2

1 reference

22 May 2018

Lijia Zhang

series ordinal

3

1 reference

22 May 2018

Songhua Hu

series ordinal

4

1 reference

22 May 2018

language of work or name

English

0 references

publication date

1 April 2012

1 reference

22 May 2018

published in

Vaccine

1 reference

22 May 2018

volume

30

1 reference

22 May 2018

issue

27

1 reference

22 May 2018

page(s)

4106-4112

1 reference

22 May 2018

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

1 reference

Comparison of the pharmacological effects of Panax ginseng and Panax quinquefolium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Current evaluation of the millennium phytomedicine--ginseng (I): etymology, pharmacognosy, phytochemistry, market and regulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Ginseng and aluminium hydroxide act synergistically as vaccine adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Effects of Chinese herbal medicinal ingredients on peripheral lymphocyte proliferation and serum antibody titer after vaccination in chicken

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Ginsenoside Rg1 enhances immune response induced by recombinant Toxoplasma gondii SAG1 antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Ginseng extract in aluminium hydroxide adjuvanted vaccines improves the antibody response of pigs to porcine parvovirus and Erysipelothrix rhusiopathiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

The Rb1 fraction of ginseng elicits a balanced Th1 and Th2 immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Expression and distribution of Toll-like receptors 11-13 in the brain during murine neurocysticercosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Toll-like receptor 8-mediated activation of murine plasmacytoid dendritic cells by vaccinia viral DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

TLR11 activation of dendritic cells by a protozoan profilin-like protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Transcriptional regulation of the novel Toll-like receptor Tlr13.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Human TLRs 10 and 1 share common mechanisms of innate immune sensing but not signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

The role of Toll-like receptors in the host response to viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Mouse toll-like receptor 4.MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Improvement of a commercial foot-and-mouth disease vaccine by supplement of Quil A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Novel polysaccharide adjuvant from the roots of Actinidia eriantha with dual Th1 and Th2 potentiating activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Paclitaxel acts as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Quantitative expression profiling of immune response genes in rainbow trout following infectious haematopoietic necrosis virus (IHNV) infection or DNA vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Adjuvant effects of protopanaxadiol and protopanaxatriol saponins from ginseng roots on the immune responses to ovalbumin in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Enhancement of immune responses to influenza vaccine (H3N2) by ginsenoside Re.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Ginsenoside Rg1 and aluminum hydroxide synergistically promote immune responses to ovalbumin in BALB/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Sympathetic nervous system modulation of the immune system. III. Alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Natural products as targeted modulators of the nuclear factor-kappaB pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Achieving stability of lipopolysaccharide-induced NF-kappaB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Adjuvant activities of saponins from traditional Chinese medicinal herbs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.052

10.1016/J.VACCINE.2012.03.052

7 January 2021

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018